Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Montana › Great Falls
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Great Falls, MT keessatti
Qorannoo 9 Kansara Qara'a Non-Small Cell f Great Falls fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Namoota walitti qabaa jiraSadarkaa 3
- Benefis Sletten Cancer Institute, Great Falls
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- Benefis Sletten Cancer Institute, Great Falls
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Namoota walitti qabaa jiraSadarkaa 3
- Benefis Sletten Cancer Institute, Great Falls
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Namoota walitti qabaa jiraSadarkaa 2
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Benefis Sletten Cancer Institute, Great Falls
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Benefis Sletten Cancer Institute, Great Falls
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Benefis Sletten Cancer Institute, Great Falls
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Benefis Sletten Cancer Institute, Great Falls
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Namoota walitti qabaa jiraQorannoo ilaalaa
- Benefis Sletten Cancer Institute, Great Falls
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Great Falls keessatti
- Kansarii ProstateQorannoo 10
- Dhibee QaraQorannoo 9
- Leukemia Myeloidii HamaaQorannoo 6
- Dukkana BladderQorannoo 5
- Saree OljooQorannoo 5
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 5
- Kansarii ColorectalQorannoo 5
- MelanomaQorannoo 5
- Kansarii KoloniiQorannoo 4
- Kansa EndometiriyaaliiQorannoo 3
- Kansarii RektumiiQorannoo 3
- Luukemiya Limfoositiikii KeessummaaQorannoo 3
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.